Call Options Transactions Made in Q1 2024 in Eye Point Pharmaceuticals, Inc. (EYPT)
This table provides information about the institutional ownership of Eye Point Pharmaceuticals, Inc. (EYPT) during Q1 2024. The information is specifically focused on institutions that hold call options of EyePoint Pharmaceuticals, Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
May 15, 2024
Q1 2024
|
Caption Management, LLC
Oklahoma City, OK |
SELL
|
CALL |
-13.3K- 8.87% |
$265K - $395K
|
137K
$1.1M
|
|
|
May 15, 2024
Q1 2024
|
Boothbay Fund Management, LLC
New York, NY |
SELL
|
CALL |
-32.1K- 34.33% |
$640K - $954K
|
61.4K
$494K
|
|
|
May 15, 2024
Q1 2024
|
Ikarian Capital, LLC
Dallas, TX |
SELL
|
CALL |
-185K- 47.19% |
$3.68M - $5.48M
|
207K
$1.66M
|
|
|
May 07, 2024
Q1 2024
|
Susquehanna International Group, LLP
Bala Cynwyd, PA |
SELL
|
CALL |
-297K- 52.92% |
$5.92M - $8.82M
|
264K
$2.12M
|
|
|
May 15, 2024
Q1 2024
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
SELL
|
CALL |
-404K- 80.89% |
$8.04M - $12M
|
95.3K
$766K
|